Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders

被引:14
作者
Eser, Ahmet [1 ]
Devranoglu, Belgin [1 ]
Ergen, Evrim Bostanci [1 ]
Abide, Cigdem Yayla [1 ]
机构
[1] Istanbul Zeynep Kamil Woman & Child Dis Training, Dept Gynecol Obstet & Reprod Med, Istanbul, Turkey
关键词
Dual trigger; intracytoplasmic sperm injection; poor responders;
D O I
10.4274/jtgga.2017.0045
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To compare metaphase II (MII) rate, fertilization rate, and embryo quality with dual trigger gonadotropin-releasing hormone agonist (GnRH) and normal dose human chorionic gonadotropin (hCG) versus a normal dose hCG trigger in antagonist intracytoplasmic sperm injection (ICSI) cycles of poor ovarian responders. Material and Methods: Patients defined as poor ovarian responders according to the Bologna criteria who underwent ICSI with GnRH antagonist protocol and triggered with dual trigger or hCG alone for oocyte maturation. Main outcome measures were MII rate, fertilization rate, and embryo quality. Results: Total gonadotropin doses and E-2 levels on trigger day were higher in the hCG trigger group. There were no significant differences with regard to implantation rate (p=0.304), biochemical pregnancy rate (p=0.815), clinical pregnancy rate (p=0.378), and ongoing pregnancy rate (p=0.635) between the groups. Conclusion: Dual trigger of oocyte maturation with GnRH agonist and normal dose hCG in poor responders does not demonstrate improved oocyte maturation, clinical pregnancy, and ongoing pregnancy rates.
引用
收藏
页码:98 / 103
页数:6
相关论文
共 29 条
[1]   Serum inhibin A, VEGF and TNFα levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment:: a prospective randomized trial [J].
Babayof, R ;
Margalioth, EJ ;
Huleihel, M ;
Amash, A ;
Zylber-Haran, E ;
Gal, M ;
Brooks, B ;
Mimoni, T ;
Eldar-Geva, T .
HUMAN REPRODUCTION, 2006, 21 (05) :1260-1265
[2]   Empty follicle syndrome: successful treatment in a recurrent case and review of the literature [J].
Beck-Fruchter, R. ;
Weiss, A. ;
Lavee, M. ;
Geslevich, Y. ;
Shalev, E. .
HUMAN REPRODUCTION, 2012, 27 (05) :1357-1367
[3]  
Decleer W, 2014, FACTS VIEWS VIS OBGY, V6, P203
[4]   The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study [J].
Engmann, Lawrence ;
DiLuigi, Andrea ;
Schmidt, David ;
Nulsen, John ;
Maier, Donald ;
Benadiva, Claudio .
FERTILITY AND STERILITY, 2008, 89 (01) :84-91
[5]   ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria [J].
Ferraretti, A. P. ;
La Marca, A. ;
Fauser, B. C. J. M. ;
Tarlatzis, B. ;
Nargund, G. ;
Gianaroli, L. .
HUMAN REPRODUCTION, 2011, 26 (07) :1616-1624
[6]  
GONEN Y, 1990, J CLIN ENDOCR METAB, V71, P917
[7]   Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates [J].
Griffin, Daniel ;
Feinn, Richard ;
Engmann, Lawrence ;
Nulsen, John ;
Budinetz, Tara ;
Benadiva, Claudio .
FERTILITY AND STERILITY, 2014, 102 (02) :405-409
[8]   Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles-a preliminary report [J].
Haas, Jigal ;
Zilberberg, Eran ;
Dar, Shir ;
Kedem, Alon ;
Machtinger, Ronit ;
Orvieto, Raoul .
JOURNAL OF OVARIAN RESEARCH, 2014, 7
[9]   GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles:: a prospective randomized study [J].
Humaidan, P ;
Bredkjær, HE ;
Bungum, L ;
Bungum, M ;
Grondahl, ML ;
Westergaard, L ;
Andersen, CY .
HUMAN REPRODUCTION, 2005, 20 (05) :1213-1220
[10]  
Jelodar GA, 2007, INDIAN J EXP BIOL, V45, P242